Compare GSK & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSK | ABT |
|---|---|---|
| Founded | 1715 | 1888 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7B | 152.9B |
| IPO Year | 2013 | 2006 |
| Metric | GSK | ABT |
|---|---|---|
| Price | $49.41 | $111.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 20 |
| Target Price | N/A | ★ $130.90 |
| AVG Volume (30 Days) | 4.4M | ★ 8.2M |
| Earning Date | 04-29-2026 | 04-16-2026 |
| Dividend Yield | ★ 3.40% | 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $6.99 | $10.75 |
| Revenue Next Year | $4.19 | $8.10 |
| P/E Ratio | ★ $32.75 | $182.43 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $38.63 | $81.97 |
| 52 Week High | $61.70 | $137.49 |
| Indicator | GSK | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 37.29 | 73.52 |
| Support Level | $48.02 | $111.18 |
| Resistance Level | $51.79 | $113.76 |
| Average True Range (ATR) | 0.91 | 2.45 |
| MACD | -0.26 | 0.17 |
| Stochastic Oscillator | 5.77 | 91.65 |
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.